World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
49
Citations
10947
World Ranking
4538
National Ranking
131

Overview

Viviane D. Lima is affiliated with the University of British Columbia in Canada. Their research is primarily situated within the field of Medicine, with a significant focus on Infectious Diseases, Epidemiology, and Emergency Medicine. Other subfields include Virology and General Health Professions.

The scientist's work extensively covers topics related to HIV/AIDS research and interventions. Key topics also include HIV, drug use, and sexual risk; HIV-related health complications and treatments; HIV research and treatment; HIV/AIDS drug development and treatment; Pneumocystis jirovecii pneumonia detection and treatment; and homelessness and social issues.

Frequent venues for publication include UNC Libraries, Clinical Infectious Diseases, BMJ Open, PLoS ONE, and AIDS. These platforms have hosted multiple research outputs from them, indicating active contributions to literature in clinical and public health domains.

Viviane D. Lima has collaborated repeatedly with several co-authors, names of whom include Julio Montaner, Richard D. Moore, Robert S. Hogg, Keri N. Althoff, and Michael A. Horberg. These partnerships reflect a network of researchers engaged in overlapping areas of study concerning HIV and related health issues.

Recent papers authored or co-authored by Viviane D. Lima cover multiple aspects of HIV treatment and associated conditions. Noteworthy publications include:

  • Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada (2020), Journal of the International AIDS Society
  • Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada (2020), Clinical Infectious Diseases
  • Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study (2021), BMJ Open
  • Mortality Among Persons Entering HIV Care Compared With the General U.S. Population (2021), Annals of Internal Medicine
  • Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada (2020), PLoS Medicine

Best Publications

  • Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

    R Hogg;V Lima;J Sterne;S Grabar

  • Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

    Julio S.G. Montaner;Julio S.G. Montaner;Julio S.G. Montaner;Viviane D. Lima;Viviane D. Lima;Rolando Barrios;Benita Yip

  • Validating a Shortened Depression Scale (10 Item CES-D) among HIV-Positive People in British Columbia, Canada

    Wendy Zhang;Nadia O’Brien;Jamie I. Forrest;Kate A. Salters

  • Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals

    Natasha K. Martin;Peter Vickerman;Jason Grebely;Margaret Hellard

  • Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting

    Julio S.G. Montaner;Viviane D. Lima;P. Richard Harrigan;Lillian Lourenço

  • The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

    Viviane D Lima;Richard Harrigan;David R Bangsberg;Robert S Hogg;Robert S Hogg

  • Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.

    Viviane D. Lima;Robert S. Hogg;P. Richard Harrigan;David Moore

  • Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

    Ravindra K Gupta;Andrew Hill;Anthony W Sawyer;Alessandro Cozzi-Lepri

  • The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART.

    Viviane D. Lima;Josie Geller;David R. Bangsberg;Thomas L. Patterson

  • Expanded Access to Highly Active Antiretroviral Therapy: A Potentially Powerful Strategy to Curb the Growth of the HIV Epidemic

    Viviane D. Lima;Karissa Johnston;Karissa Johnston;Robert S. Hogg;Adrian R. Levy;Adrian R. Levy

  • The association between food insecurity and mortality among HIV-infected individuals on HAART

    Sheri D Weiser;Kimberly A Fernandes;Eirikka K Brandson;Viviane D Lima

  • The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.

    Bohdan Nosyk;Bohdan Nosyk;Julio S G Montaner;Guillaume Colley;Viviane D Lima

  • Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

    Evan Wood;Robert S. Hogg;Viviane Dias Lima;Thomas Kerr

  • Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.

    Robert S Hogg;Robert S Hogg;David R Bangsberg;Viviane D Lima;Chris Alexander

  • Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.

    Kassem Bourgi;Kassem Bourgi;Cathy A Jenkins;Peter F Rebeiro;Frank Palella

  • Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.

    Viviane D. Lima;Richard Harrigan;Melanie Murray;David M. Moore

  • Antiretroviral therapy cohort collaboration : life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

    R. Hogg;V. Lima;J. A. Sterne;S. Grabar

  • N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.

    Soo Huey Yap;Soo Huey Yap;Chih-Wei Sheen;Jonathan Phillip Fahey;Jonathan Phillip Fahey;Mark Zanin

  • Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level.

    Viviane D. Lima;David R. Bangsberg;P. Richard Harrigan;Steven G. Deeks

  • Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting.

    Ruth Joy;Eric F Druyts;Eirikka K Brandson;Viviane D Lima

  • The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users

    Seonaid Nolan;Seonaid Nolan;Viviane Dias Lima;Viviane Dias Lima;Nadia Fairbairn;Thomas Kerr;Thomas Kerr

  • Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection.

    Vikram S. Gill;Viviane D. Lima;Viviane D. Lima;Wen Zhang;Brian Wynhoven

  • Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012

    Oghenowede Eyawo;Conrado Franco-Villalobos;Mark W Hull;Adriana Nohpal

Frequent Co-Authors

Julio S. G. Montaner
Julio S. G. Montaner University of British Columbia
Robert S. Hogg
Robert S. Hogg Simon Fraser University
Benita Yip
Benita Yip University of British Columbia
Evan Wood
Evan Wood University of British Columbia
P. Richard Harrigan
P. Richard Harrigan University of British Columbia
Thomas Kerr
Thomas Kerr University of British Columbia
Michael S. Saag
Michael S. Saag University of Alabama at Birmingham
David R. Bangsberg
David R. Bangsberg Simon Fraser University
Mel Krajden
Mel Krajden University of British Columbia
Jason Grebely
Jason Grebely University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various online degrees and career opportunities beyond traditional lab roles. For individuals with unique challenges, such as those wondering what can a felon go to college for, there are accessible programs in related healthcare and science fields that offer a fresh start.

One promising direction is becoming a functional medicine nurse practitioner programs, which combine medical knowledge with holistic patient care and have growing demand in the healthcare system.

Additionally, careers in health information, such as medical coding or health data management, provide essential support to healthcare providers. Exploring roles like certified professional coder salary and responsibilities can reveal viable paths that leverage microbiology knowledge in the administrative and technical side of medicine.

For those interested in management, the role of a health information management job description and salary highlights opportunities to oversee medical records and data systems, a crucial function ensuring healthcare quality and compliance.

Best Scientists Citing Viviane D. Lima

Trending Scientists

Recently Published Articles